OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

A former OpenAI researcher is raising $2 billion to start a company focused on using AI to discover new drugs. This signals investor confidence in AI for medicine, which could lead to faster drug development and new treatments.